Funded Awards – December 2018

Funded Awards
PI Agency Title
Eve Colson NIH/R01/Boston University Social Confounders for Health Outcomes Linked to Educa…
Patricia Dickson NIH/R44/Phoenix Nest Development and Validation of Therapy for Mucopolysacc…
Todd Druley SLCH Foundation/Restricted Funding Request Directed differentiation of infant leukemia patient in…
Robert Hayashi St. Baldrick’s Foundation/The Children’s Hospital of Philadelphia LEAHRN (Late Effects After High-Risk Neuroblastoma)
Ellen Kim CDTR Group Intervention Program for High-risk Youth with Po…
Mark Manary The Innocent Foundation Treatment of High-Risk Moderate Acute Malnutrition Usi…
S. Celeste Morley NIH/R21 Human Variant in CoQ Biosynthesis Impairs Lung Immunit…
Jessica Pittman Cystic Fibrosis Foundation Therapeutics, Inc. Determinants of Change in Lung Function During Pulmona…
Funded Awards
Funded Grants March 2022

PI Agency Title Andrew Cluster University of California A Phase 1 Study of Modified Measles Virus (MV-NIS) for the Treatment of Children and Young Adults with Recurrent Medulloblastoma or Recurrent Atypical Teratoid Rhabdoid Tumors (ATRT) Jonathan Cooper NIH/R21 Defining and treating peripheral nervous system dysfunction in Cln1 disease Megan Cooper …

Funded Awards
Funded Grants February 2022

PI Agency Title Tarin Bigley Rheumatology Research Foundation/Scientist Development Award Evaluating the role of neonatal infections in systemic lupus erythematosus Jane Garbutt NIH/UL1 Washington University Institute of Clinical and Translational Sciences (ISP, JG) (WUPAARC) Bryan Sisk SLCH Foundation Transitioning from hospital-based care to home-based care for pediatric patients and families …

Funded Awards
Funded Grants January 2022

PI Agency Title Mohamed Abdelbaki SLCH Foundation Neuro-Onc Fellowship Year 2 Sarah Garwood SLCH Foundation The SPOT at Jennings High School (A School-Based Health Center) Robert Hayashi St. Baldrick’s Foundation/Children’s Hospital of Philadelphia Health Effects After Anthracycline and Radiation Therapy (HEART) – Dexazoxane and Prevention of Anythracycline-related Cardiomyopathy (ALTE11C2) Jennifer …